Page 1232 - Williams Hematology ( PDFDrive )
P. 1232

1206  Part IX:  Lymphocytes and Plasma Cells             Chapter 79:  Lymphocytosis and Lymphocytopenia              1207




                    19.  Molica S, Mauro FR, Giannarelli D, et al: Differentiating chronic lymphocytic leuke-    48.  Granados E, Llamas P, Pinilla I, et al: Persistent polyclonal B lymphocytosis with multi-
                     mia from monoclonal B-lymphocytosis according to clinical outcome: On behalf of   ple bcl-2/IgH rearrangements: A benign disorder. Haematologica 83(4):369–375, 1998.
                     the  GIMEMA chronic lymphoproliferative diseases working group.  Haematologica     49.  Mossafa H, Tapia S, Flandrin G, Troussard X: Chromosomal instability and ATR ampli-
                     96(2):277–283, 2011.                                  fication gene in patients with persistent and polyclonal B-cell lymphocytosis (PPBL).
                    20.  Shanafelt TD, Kay NE, Jenkins G, et al: B-cell count and survival: Differentiating   Leuk Lymphoma 45(7):1401–1406, 2004.
                     chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical     50.  Lancry L, Roulland S, Roue G, et al: No BCL-2 protein over expression but BCL-2/IgH
                     outcome. Blood 113(18):4188–4196, 2009.               rearrangements in B cells of patients with persistent polyclonal B-cell lymphocytosis.
                    21.  Shanafelt TD, Kay NE, Rabe KG, et al: Brief report: Natural history of individuals with   Hematol J 2(4):228–233, 2001.
                     clinically recognized monoclonal B-cell lymphocytosis compared with patients with     51.  Dasanu CA, Codreanu I: Persistent polyclonal B-cell lymphocytosis in chronic smok-
                     Rai 0 chronic lymphocytic leukemia. J Clin Oncol 27(24):3959–3963, 2009.  ers: More than meets the eye. Conn Med 76(2):69–72, 2012.
                    22.  Rossi D, Sozzi E, Puma A, et al: The prognosis of clinical monoclonal B cell lymphocy-    52.  Bassan R, Spinelli O, Rambaldi A, Barbui T: The course of monoclonal “villous” lym-
                     tosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated   phocytosis over 15 years of follow-up: Progression to SLVL or spontaneous clinical but
                     by biological risk factors. Br J Haematol 146(1):64–75, 2009.  not molecular remission. Leukemia 17(11):2243–2244, 2003.
                    23.  Fazi C, Scarfo L, Pecciarini L, et al: General population low-count CLL-like MBL per-    53.  Cornet E, Lesesve JF, Mossafa H, et al: Long-term follow-up of 111 patients with
                     sists over time without clinical progression, although carrying the same cytogenetic   persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.  Leukemia
                     abnormalities of CLL. Blood 118(25):6618–6625, 2011.  23(2):419–422, 2009.
                    24.  Moreira J, Rabe KG, Cerhan JR, et al: Infectious complications among individuals with     54.  Hudnall SD, Patel J, Schwab H, Martinez J: Comparative immunophenotypic features
                     clinical monoclonal B-cell lymphocytosis (MBL): A cohort study of newly diagnosed   of EBV-positive and EBV-negative atypical lymphocytosis. Cytometry B Clin Cytom
                     cases compared to controls. Leukemia 27(1):136–141, 2013.  55(1):22–28, 2003.
                    25.  Deplano S, Nadal-Melsio E, Bain BJ: Persistent polyclonal B lymphocytosis.  Am J     55.  Balfour HH Jr, Odumade OA, Schmeling DO, et al: Behavioral, virologic, and immu-
                     Hematol 89(2):224, 2014.                              nologic factors associated with acquisition and severity of primary Epstein-Barr virus
                    26.  Berkowska MA, Grosserichter-Wagener C, Adriaansen HJ, et al: Persistent polyclonal   infection in university students. J Infect Dis 207(1):80–88, 2013.
                     B-cell lymphocytosis: Extensively proliferated CD27+IgM+IgD+ memory B cells with     56.  Horwitz MS, Moore GT: Acute infectious lymphocytosis. An etiologic and epidemio-
                     a distinctive immunophenotype. Leukemia 28(7):1560–1564, 2014.  logic study of an outbreak. N Engl J Med 279(8):399–404, 1968.
                    27.  Chevalier C, Husson B, Detry G: Polyclonal B lymphocytosis with binucleated lympho-    57.  Yetgin S, Kuskonmaz B, Aytac S, Tavil B: An unusual case of reactive lymphocytosis
                     cytes in a man. Am J Hematol 88(1):86, 2013.          mimicking acute leukemia. Pediatr Hematol Oncol 24(2):129–135, 2007.
                    28.  Lesesve JF, Troussard X: Persistent polyclonal B-cell lymphocytosis. Blood 118(25):6485,     58.  Kunno A,  Abe M,  Yamada M, Murakami K: Clinical  and histological features  of
                     2011.                                                 cytomegalovirus hepatitis in previously healthy adults. Liver 17(3):129–132, 1997.
                    29.  Lesesve JF, Gressot AL, Troussard X, et al: Morphologic features of binucleated lym-    59.  Labalette M, Salez F, Pruvot FR, et al: CD8 lymphocytosis in primary cytomegalovirus
                     phocytes to assess the diagnosis of persistent B-cell polyclonal lymphocytosis or other   (CMV) infection of allograft recipients: Expansion of an uncommon CD8+ CD57–
                     mature B-cell neoplasms. Leuk Lymphoma 55(7):1551–1556, 2014.  subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol
                    30.  Delage R, Roy J, Jacques L, et al: Multiple bcl-2/Ig gene rearrangements in persistent   95(3):465–471, 1994.
                     polyclonal B-cell lymphocytosis. Br J Haematol 97(3):589–595, 1997.    60.  Labalette M, Salez F, Pruvot FR, et al: Successive emergence of two CD8 subsets in
                    31.  Schmidt-Hieber M, Burmeister T, Weimann A, et al: Combined automated cell and   primary CMV infection of allograft recipients. Transpl Int 7 (Suppl 1):S611–S617, 1994.
                     flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocy-    61.  Arnez M, Cizman M, Jazbec J, Kotnik A: Acute infectious lymphocytosis caused by
                     tosis (PPBL), a study of 25 patients. Ann Hematol 87(10):829–836, 2008.  coxsackievirus B2. Pediatr Infect Dis J 15(12):1127–1128, 1996.
                    32.  Himmelmann A, Gautschi O, Nawrath M, et al: Persistent polyclonal B-cell lympho-    62.  Ferronato AE, Gilio AE, Vieira SE: Respiratory viral infections in infants with clinically
                     cytosis is an expansion of functional IgD(+)CD27(+) memory B cells. Br J Haematol   suspected pertussis. J Pediatr (Rio J) 89(6):549–553, 2013.
                     114(2):400–405, 2001.                                63.  Hodge G, Hodge S, Markus C, Lawrence A, Han P: A marked decrease in L-selectin
                    33.  Loembe MM, Neron S, Delage R, Darveau A: Analysis of expressed V(H) genes in   expression by leucocytes in infants with Bordetella pertussis infection: Leucocytosis
                     persistent polyclonal B cell lymphocytosis reveals absence of selection in CD27+IgM+   explained? Respirology 8(2):157–162, 2003.
                     IgD+ memory B cells. Eur J Immunol 32(12):3678–3688, 2002.    64.  Verschueren H, Dewit J, Van der Wegen A, et al: The lymphocytosis promoting action
                    34.  Salcedo I, Campos-Caro A, Sampalo A, et al: Persistent polyclonal B lymphocytosis:   of pertussis toxin can be mimicked in vitro. Holotoxin but not the B subunit inhibits
                     An expansion of cells showing IgVH gene mutations and phenotypic features of nor-  invasion of human T lymphoma cells through fibroblast monolayers. J Immunol Meth-
                     mal lymphocytes from the CD27+ marginal zone B-cell compartment. Br J Haematol   ods 144(2):231–240, 1991.
                     116(3):662–666, 2002.                                65.  Suzuki G, Sawa H, Kobayashi Y, et al: Pertussis toxin-sensitive signal controls the traf-
                    35.  Roussel M, Roue G, Sola B, et al: Dysfunction of the Fas apoptotic signaling pathway in   ficking of thymocytes across the corticomedullary junction in the thymus. J Immunol
                     persistent polyclonal B-cell lymphocytosis. Haematologica 88(2):239–240, 2003.  162(10):5981–5985, 1999.
                    36.  Troussard X, Mossafa H, Salaun V: Persistent polyclonal lymphocytosis (PPLB). Leuke-    66.  Witvliet MH, Vogel ML, Wiertz EJ, Poolman JT: Interaction of pertussis toxin with
                     mia 13(3):497–498, 1999.                              human T lymphocytes. Infect Immun 60(12):5085–5090, 1992.
                    37.  Carr R, Fishlock K, Matutes E: Persistent polyclonal B-cell lymphocytosis in identical     67.  Kwon HJ, Yum SK, Choi UY, et al: Infant pertussis and household transmission in
                     twins. Br J Haematol 96(2):272–274, 1997.             Korea. J Korean Med Sci 27(12):1547–1551, 2012.
                    38.  Delage R, Jacques L, Massinga-Loembe M, et al: Persistent polyclonal B-cell lymphocy-    68.  Lima M, Almeida J, Dos Anjos Teixeira M, et al: TCRalphabeta+/CD4+ large gran-
                     tosis: Further evidence for a genetic disorder associated with B-cell abnormalities. Br J   ular lymphocytosis: A new clonal T-cell lymphoproliferative disorder.  Am J Pathol
                     Haematol 114(3):666–670, 2001.                        163(2):763–771, 2003.
                    39.  Wolowiec D, Nowak J, Majewski M, et al: High incidence of ancestral HLA haplotype     69.  Moura J, Rodrigues J, Santos AH, et al: Chemokine receptor repertoire reflects mature
                     8.1 and monoclonal incomplete DH-JH immunoglobulin heavy chain gene rearrange-  T-cell lymphoproliferative disorder clinical presentation.  Blood Cells Mol Dis 42(1):
                     ment in persistent polyclonal B-cell lymphocytosis. Ann Hematol 87(7):597–598, 2008.  57–63, 2009.
                    40.  Feugier P, De March AK, Lesesve JF, et al: Intravascular bone marrow accumulation     70.  Rabbani GR, Phyliky RL, Tefferi A: A long-term study of patients with chronic natural
                     in persistent polyclonal lymphocytosis: A misleading feature for B-cell neoplasm. Mod   killer cell lymphocytosis. Br J Haematol 106(4):960–966, 1999.
                     Pathol 17(9):1087–1096, 2004.                        71.  O’Malley DP: T-cell large granular leukemia and related proliferations. Am J Clin Pathol
                    41.  Del Giudice I, Pileri SA, Rossi M, et al: Histopathological and molecular features of   127(6):850–859, 2007.
                     persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. Br J     72.  Poullot E, Zambello R, Leblanc F, et al: Chronic natural killer lymphoproliferative
                     Haematol 144(5):726–731, 2009.                        disorders: Characteristics of an international cohort of 70 patients. Ann Oncol 25(10):
                    42.  Okamoto A, Inaba T, Fujita N: The role of interleukin-6 in a patient with polyclonal   2030–2035, 2014.
                     hairy B-cell lymphoproliferative disorder: A case report. Lab Hematol 13(4):124–127,     73.  Kim D, Al-Dawsari G, Chang H, et al: Large granular lymphocytosis and its impact
                     2007.                                                 on  long-term clinical outcomes following allo-SCT.  Bone Marrow Transplant 48(8):
                    43.  Machii T, Yamaguchi M, Inoue R, et al: Polyclonal B-cell lymphocytosis with features   1104–1111, 2013.
                     resembling hairy cell leukemia-Japanese variant. Blood 89(6):2008–2014, 1997.    74.  Rossi D, Franceschetti S, Capello D, et al: Transient monoclonal expansion of CD8+/
                    44.  Mossafa H, Malaure H, Maynadie M, et al: Persistent polyclonal B lymphocytosis with   CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection. Am
                     binucleated lymphocytes: A study of 25 cases. Groupe Francais d’Hematologie Cellu-  J Hematol 82(12):1103–1105, 2007.
                     laire. Br J Haematol 104(3):486–493, 1999.           75.  Myers B, Speight EL, Huissoon AP, Davies JM: Natural killer-cell lymphocytosis and
                    45.  Callet-Bauchu E, Renard N, Gazzo S, et al: Distribution of the cytogenetic abnormality   strongyloides infection. Clin Lab Haematol 22(4):237–238, 2000.
                     +i(3)(q10) in persistent polyclonal B-cell lymphocytosis: A FICTION study in three     76.  Granjo E, Lima M, Fraga M, et al: Abnormal NK cell lymphocytosis detected after sple-
                     cases. Br J Haematol 99(3):531–536, 1997.             nectomy: Association with repeated infections, relapsing neutropenia, and persistent
                    46.  Espinet B, Florensa L, Sole F, et al: Isochromosome +i(3)(q10) in a new case of persis-  polyclonal B-cell proliferation. Int J Hematol 75(5):484–488, 2002.
                     tent polyclonal B-cell lymphocytosis (PPBL). Eur J Haematol 64(5):344–346, 2000.    77.  Vanness ER, Davis MD, Tefferi A: Cutaneous findings associated with chronic natural
                    47.  Samson T, Mossafa H, Lusina D, et al: Dicentric chromosome 3 associated with binu-  killer cell lymphocytosis. Int J Dermatol 41(12):852–857, 2002.
                     cleated lymphocytes in atypical B-cell chronic lymphoproliferative disorder. Leuk Lym-    78.  Kaito K, Otsubo H, Ogasawara Y, et al: Severe aplastic anemia associated with chronic
                     phoma 43(9):1749–1754, 2002.                          natural killer cell lymphocytosis. Int J Hematol 72(4):463–465, 2000.







          Kaushansky_chapter 79_p1199-1210.indd   1207                                                                  9/17/15   4:07 PM
   1227   1228   1229   1230   1231   1232   1233   1234   1235   1236   1237